RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

>>The potential outcomes remain the same:
An onerous financing followed by a partnership.
OR, if the partner really is just playing with them:
An onerous financing followed by a sale of the company.


I think that what is more likely is a slap-dash liquidation of the company -- no financing required, because the low price will offset the risks associated with truncated due dilligence.

I don't think cor management has the credibility to get a counterparty to offer them a loan to get through the M/A process. If they had the credibility to do that, they'd have done a financing by now. They'll just have to let the whole thing go at a heinous discount.